ArticleThe Journal of allergy and clinical immunology2026
Radical-induced lipid oxidation produces a torrent of leukotriene-like agonists in severe asthma.
Article in The Journal of allergy and clinical immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
backgroundWe discovered a family of cysteinyl leukotriene (CysLT)-like biomolecules, pseudo leukotrienes (øLTs), produced through radical-induced oxidation of arachidonate.
objectiveWe sought to test hypotheses that øLT levels are elevated in asthma and that øLTs induce CysLT receptor-dependent inflammatory signaling in bronchial epithelial cells.
methodsLiquid chromatography-tandem mass spectrometry analysis determined levels of øLTs in urine from human subjects and in lung samples from mice exposed to house dust mite extract. Inflammatory signaling induced by øLTs and CysLTs in human bronchial epithelial cells were compared.
resultsMean urinary øLTC and øLTD concentrations were elevated 4-fold (P = .004) to 5-fold (P = .0015) in severe asthma. Adding øLTC+øLTD improved the statistical significance of the differences between controls and moderate (P = .0004) or severe (P = .00008) asthma. Pulmonary øLT concentrations were elevated 100% in mice after allergen exposure. øLTs induced phosphorylation of extracellular signal-regulated kinase and protein kinase B (Akt) in bronchial epithelial cells, which was inhibited by CysLT receptor antagonists.
conclusionsUrinary øLTs are new biomarkers that may facilitate noninvasive assessment of asthma severity and the efficacy of therapeutic measures. Presumably øLTs contribute to CysLT receptor-mediated inflammation through CysLT-like inflammatory biological activities previously ascribed uniquely to CysLTs. øLTs provide a mechanistic link between radical-induced biochemistry, activation of the extracellular signal-regulated kinase/Akt pathway, and asthma. These discoveries require re-examination of long-held disease paradigms for the involvement of CysLTs in asthma pathology and reconsideration of the mechanistic basis for the efficacy of CysLT receptor antagonists for ameliorating chronic asthma. Inhibiting the biosynthesis of øLTs may provide new therapeutic strategies for preventing asthmatic inflammation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.